Published in J Neurochem on July 01, 1979
Tyrosine hydroxylase regulation in the central nervous system. Mol Cell Biochem (1983) 0.89
Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab (1996) 1.99
Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther (1992) 1.72
Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci (1981) 1.55
Adenosine triphosphate stimulates inositol phospholipid metabolism and prostacyclin formation in adrenal medullary endothelial cells by means of P2-purinergic receptors. Proc Natl Acad Sci U S A (1987) 1.48
A new salutary resuscitative fluid: liposome encapsulated hemoglobin/hypertonic saline solution. J Trauma (1993) 1.42
Limitations of the captopril test in the diagnosis of renovascular hypertension. Isr J Med Sci (1991) 1.40
Blood pressure measurement method not responsible for results of Brands et al. Am J Hypertens (1994) 1.39
Immunohistochemical localization of a melanin concentrating hormone-like peptide in the rat brain. Brain Res Bull (1985) 1.34
Effect of co-trimoxazole on normal creatinine clearance. Lancet (1978) 1.23
Evidence for the existence of atrial natriuretic factor-containing neurons in the rat brain. Neuroendocrinology (1985) 1.21
Polydipsia induced by isoprenaline and by lithium: relation to kidneys and renin. Eur J Pharmacol (1972) 1.20
Intrinsic GABAergic system of adrenal chromaffin cells. Proc Natl Acad Sci U S A (1984) 1.20
Breathing 100% oxygen after global brain ischemia in Mongolian Gerbils results in increased lipid peroxidation and increased mortality. Stroke (1987) 1.12
Distribution of immunoreactive melanin-concentrating hormone in the central nervous system of the rat. Brain Res (1986) 1.07
The effect of the fast of Ramadan on ambulatory blood pressure in treated hypertensives. J Hum Hypertens (2001) 1.05
Prostacyclin reversal of lethal endotoxemia in dogs. J Clin Invest (1981) 1.05
ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. J Appl Physiol (1985) (1993) 0.98
Vascular effects of lipopolysaccharide are enhanced in interleukin-10-deficient mice. Stroke (1999) 0.98
The differential effect of Li + on microsomal ATPase in cortex, medulla and papilla of the rat kidney. Biochim Biophys Acta (1973) 0.98
Renin-angiotensin mediation of adrenal catecholamine secretion induced by haemorrhage. Eur J Pharmacol (1977) 0.98
Prostaglandins, leukotrienes, and platelet-activating factor in shock. Annu Rev Pharmacol Toxicol (1987) 0.98
Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. Circ Res (1991) 0.97
The influence of cold or isolation stress on neuroinvasiveness and virulence of an attenuated variant of West Nile virus. Arch Virol (1989) 0.97
Stroke risk factors prepare rat brainstem tissues for modified local Shwartzman reaction. Stroke (1988) 0.95
Self-induced secondary hyperaldosteronism simulating Bartter's syndrome. Isr J Med Sci (1972) 0.94
The siesta and ambulatory blood pressure: is waking up the same in the morning and afternoon? J Hum Hypertens (1996) 0.94
Role of complement in endotoxin/platelet-activating factor-induced lung injury. J Immunol (1992) 0.93
Comparison of verapamil and captopril in elderly hypertensive subjects: results of a randomized, double-blind, crossover study. J Cardiovasc Pharmacol (1993) 0.93
Leukotrienes and the cardiovascular system. Prostaglandins (1984) 0.92
Neuroprotective effects of SKF 10,047 in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke (1992) 0.92
An improved clinically relevant sepsis model in the conscious rat. Crit Care Med (2000) 0.92
Voltage-sensitive calcium flux into bovine chromaffin cells occurs through dihydropyridine-sensitive and dihydropyridine- and omega-conotoxin-insensitive pathways. Neuroscience (1989) 0.92
Preferential secretion of adrenaline or noradrenaline by the cat adrenal in vivo in response to different stimuli. Br J Pharmacol (1971) 0.92
Hypothalamic sites for cardiovascular and sympathetic modulation by prostaglandin E2. Brain Res (1982) 0.91
Distribution of immunoreactive dynorphin in the central nervous system of the rat. Brain Res (1983) 0.91
Quantitation of perivascular monocytes and macrophages around cerebral blood vessels of hypertensive and aged rats. J Cereb Blood Flow Metab (1994) 0.91
Inhibition by PGE2 and by phenylephrine of catecholamine release from human adrenal in vitro. Eur J Pharmacol (1977) 0.91
Localization of opiate binding sites in kidney and adrenal gland of the rat. Life Sci (1983) 0.91
Chlorthalidone-induced impotence. Br Med J (1980) 0.91
Altered pain perception in hypertensive humans. Brain Res (1980) 0.91
Circulating atrial natriuretic peptides in conscious rats: regulation of release by multiple factors. Science (1986) 0.91
Mu-receptors mediate opioid cardiovascular effects at anterior hypothalamic sites through sympatho-adrenomedullary and parasympathetic pathways. Endocrinology (1983) 0.90
Acetylcholine and cAMP in adrenal medulla:indirect effect. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.90
A dynorphinergic pathway of Leu-enkephalin production in rat substantia nigra. Nature (1984) 0.90
Effect of platelet-activating factor on coronary circulation of the domestic pig. Am J Physiol (1984) 0.90
Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats. Am J Physiol (1989) 0.90
Vasopressin: an essential pressor factor for blood pressure recovery following hemorrhage. Peptides (1982) 0.90
Nitric oxide and the regulation of blood pressure in the hypertension-prone and hypertension-resistant Sabra rat. Hypertension (1996) 0.90
Angiotensin increases microsomal (Na + -K + )-ATPase activity in several tissues. Biochim Biophys Acta (1972) 0.89
The relationship between cardiovascular and pain regulatory systems. Ann N Y Acad Sci (1986) 0.89
Cardiovascular effects of rat calcitonin gene-related peptide in the conscious rat. J Pharmacol Exp Ther (1988) 0.89
Deteriorating stroke model: histopathology, edema, and eicosanoid changes following spinal cord ischemia in rabbits. Stroke (1987) 0.89
Liposome-encapsulated hemoglobin: an oxygen-carrying fluid. Circ Shock (1990) 0.88
Alpha-adrenergic stimulants, prostaglandins and catecholamine release from the adrenal gland in vitro. Prostaglandins (1975) 0.88
Blood flow and vascular permeability during motor dysfunction in a rabbit model of spinal cord ischemia. Stroke (1992) 0.88
A syndrome of inappropriate ADH secretion induced by cyclothiazide. J Clin Pharmacol New Drugs (1972) 0.88
Platelet-activating factor in stroke and brain injury. Ann Neurol (1991) 0.88
Distribution of immunoreactive atrial natriuretic peptides in the central nervous system of the rat. Brain Res (1986) 0.88
Bioavailability of potassium from a slow-release tablet. Clin Pharmacol Ther (1973) 0.88
Suppression by noradrenaline of catecholamine secretion from adrenal medulla. Eur J Pharmacol (1974) 0.87
Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo. J Lipid Mediat (1992) 0.87
Corticotropin releasing factor-like immunoreactivity in sensory ganglia and capsaicin sensitive neurons of the rat central nervous system: colocalization with other neuropeptides. Peptides (1985) 0.87
Siesta and ambulatory blood pressure monitoring. Comparability of the afternoon nap and night sleep. Am J Hypertens (1994) 0.87
Pain sensitivity and opioid activity in genetically and experimentally hypertensive rats. Brain Res (1980) 0.87
Validation of laser-Doppler flowmetry in measurement of spinal cord blood flow. Am J Physiol (1989) 0.86
Prominent white matter lesions develop in Mongolian gerbils treated with 100% normobaric oxygen after global brain ischemia. Acta Neuropathol (1990) 0.86
Distribution of immunoreactive Met-enkephalin-Arg6-Gly7-Leu8 and Leu-enkephalin in discrete regions of the rat brain. Brain Res (1985) 0.86
Increased catecholamine release from adrenal medulla by liposomes loaded with sodium or calcium ions. Biochem Pharmacol (1979) 0.86
The opioid peptides. A role in hypertension? Hypertension (1987) 0.86
mu Receptors and opioid cardiovascular effects in the NTS of rat. Peptides (1983) 0.86
Hypothalamic regulation of the cardiovascular and respiratory systems: role of specific opiate receptors. Br J Pharmacol (1983) 0.86
On the origin of dynorphin A and alpha-neo-endorphin in the substantia nigra. Neuropeptides (1984) 0.86
Identification of endothelin receptors in various regions of rat brain. Neuropeptides (1990) 0.86
Liver N-demethylating activity--temperature effect and phenobarbital induction in different species. Biochem Pharmacol (1971) 0.86
Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats. J Pharmacol Exp Ther (1993) 0.86
Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours. Br J Cancer (2011) 0.85
Opiate binding in rat hearts: modulation of binding after hemorrhagic shock. Biochem Biophys Res Commun (1985) 0.85
Melanin-concentrating hormone: unique peptide neuronal system in the rat brain and pituitary gland. Proc Natl Acad Sci U S A (1986) 0.85
Postischemic production of eicosanoids in gerbil brain. Stroke (1987) 0.85
PGE2: opposite effect on catecholamine release from phaeochromocytoma and adrenal medulla. Prostaglandins (1976) 0.85
Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig. Prostaglandins (1987) 0.85
Differential cardiovascular effects of mu, delta and kappa opiate agonists at discrete hypothalamic sites in the anesthetized rat. Life Sci (1983) 0.85
Coronary constriction by leukotriene C4, D4, and E4 in the intact pig heart. Am J Cardiol (1983) 0.85
Water intake of rats after implantation of ouabain into the hypothalamus. Am J Physiol (1967) 0.85
Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons. Brain Res (1992) 0.85
Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist. J Pharmacol Exp Ther (1990) 0.85
Effects of verapamil, dantrolene and lanthanum on catecholamine release from rat adrenal medulla. Br J Pharmacol (1979) 0.85
Potent, selective, orally active 3-oxo-1,4-benzodiazepine GPIIb/IIIa integrin antagonists. J Med Chem (1996) 0.84
Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils. Eur J Pharmacol (1992) 0.84
Neuroprotective effects of tetrodotoxin as a Na+ channel modulator and glutamate release inhibitor in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke (1994) 0.84
Separation of two strains of rats with inbred dissimilar sensitivity to Doca-salt hypertension. Experientia (1972) 0.84
Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits. Stroke (1990) 0.84
Myocardial cationic shifts induced by isoproterenol. Electron microscopic and electron probe studies. J Mol Cell Cardiol (1972) 0.84
Haloperidol-induced torsades de pointes. Chest (1990) 0.84
Evidence for activation of endothelium and monocytes in hypertensive rats. Am J Physiol (1996) 0.84
Effect of endothelin on cortical microvascular perfusion in rats. Stroke (1990) 0.84
Obstructive jaundice associated with carcinoma of the prostate. Isr J Med Sci (1975) 0.83
Dopamine partially mediates the cardiovascular effects of naloxone after spinal injury. Brain Res (1981) 0.83
Distribution of atrial natriuretic factor-like immunoreactive neurons in the rat brain. Neuroscience (1985) 0.83